Status:
COMPLETED
The Routine Use of Nasopharyngeal Airway in the Setting of Monitored Anesthesia Care During Gastrointestinal Endoscopy
Lead Sponsor:
American University of Beirut Medical Center
Conditions:
Monitored Anesthesia Care
Gastrointestinal Endoscopy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this prospective, multi-center, single-blinded randomized controlled trial is to assess the efficacy of NPA in reducing respiratory events in patients being admitted for GI endoscopy (colo...
Detailed Description
Monitored anesthesia care (MAC) is currently the dominant method of endoscopic sedation for approximately one third of all US gastroenterologists. The popularity and success of MAC can be ascribed to ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients undergoing GI endoscopy under MAC using TCI of Propofol
- Patients above 18 years old
- Patient able to give consent
- ASA classification: I, II, III
- Exclusion criteria:
- Patients with craniofacial abnormalities
- Patients with a history of recent nasal or cranial bone fracture
- Patients with a history of recent nasal or trans-sphenoidal surgery
- Patients with nasal polyposis
- Patients with a history of epistaxis
- Patients with a history of coagulopathy or on anticoagulation therapy (including patients on Aspirin not stopped 7 days prior to presentation)
- Patients with a history of allergy to Xylometazoline or local anesthetics
Exclusion
Key Trial Info
Start Date :
November 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 8 2023
Estimated Enrollment :
334 Patients enrolled
Trial Details
Trial ID
NCT04123821
Start Date
November 11 2019
End Date
November 8 2023
Last Update
February 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Christian Rouphael
Beirut, Lebanon